Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study

The potent experimental renal carcinogenesis of ochratoxin A (OTA) in male rats makes the dietary contaminant a potential factor in human oncology. We explored whether the tumour promoter sodium barbitate could shorten the otherwise long latency between exposure to toxin and tumourigenesis. Young rats, of a hybrid in which mononuclear leukaemia was rare, were given feed contaminated (5 ppm) with OTA for 36 weeks to initiate renal tumourigenesis. Some individuals were thereafter given sodium barbitate (500 ppm in drinking water) for life. Pathological outcomes were studied at or near the end of natural life. Renal tumours in males given barbitate became evident after latency of one year, but only slightly before those without barbitate. In contrast, female mammary tumourigenesis was advanced by at least 6 months synchronously in all rats given the OTA-barbitate regimen compared to tumourigenesis in controls. Diagnosis of malignant mammary angiosarcoma in a female given the OTA-barbitate regimen is a new finding in the rat. The long latency of OTA-induced renal tumourigenesis was not notably susceptible to accelerated promotion by barbitate, contrasting with an apparently marked effect of barbitate on development of mammary tumours.

[1]  R. Manderville,et al.  Structures of covalent adducts between DNA and ochratoxin a: a new factor in debate about genotoxicity and human risk assessment. , 2010, Chemical research in toxicology.

[2]  P. Mantle Minimum tolerable exposure period and maximum threshold dietary intake of ochratoxin A for causing renal cancer in male Dark Agouti rats. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  A. Vettorazzi,et al.  A different kinetic profile of ochratoxin A in mature male rats. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  J. V. van Delft,et al.  Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration. , 2008, Toxicology and applied pharmacology.

[5]  P. Mantle Interpretation of the pharmacokinetics of ochratoxin A in blood plasma of rats, during and after acute or chronic ingestion. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  J. Nagy,et al.  Binding of Ochratoxin A to a Urinary Globulin: A New Concept to Account for Gender Difference in Rat Nephrocarcinogenic Responses , 2008, International journal of molecular sciences.

[7]  D. Malarkey,et al.  Histopathology Of Hemangiosarcomas in Mice and Hamsters and Liposarcomas/Fibrosarcomas in Rats Associated with PPAR Agonists , 2007, Toxicologic pathology.

[8]  A. Brown,et al.  DNA ploidy distribution in renal tumours induced in male rats by dietary ochratoxin A. , 2007, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[9]  Heidrun Ellinger-Ziegelbauer,et al.  Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis. , 2007, Cancer research.

[10]  Suzanne M. Snedeker,et al.  Ochratoxin a: Its Cancer Risk and Potential for Exposure , 2004, Journal of toxicology and environmental health. Part B, Critical reviews.

[11]  M. Sperandio,et al.  Heterogeneity, histological features and DNA ploidy in oral carcinoma by image-based analysis. , 2005, Oral oncology.

[12]  E. Kulinskaya,et al.  Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A , 2005, Food additives and contaminants.

[13]  C. Greenacre Spontaneous tumors of small mammals. , 2004, The veterinary clinics of North America. Exotic animal practice.

[14]  H. Bartsch,et al.  Ochratoxin study , 2004, International journal of cancer.

[15]  K. Kang,et al.  Strain‐specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats , 2003, International journal of cancer.

[16]  Yu Huang,et al.  Spontaneous mammary tumors in aging Noble rats. , 2003, International journal of oncology.

[17]  T. Goldsworthy,et al.  Promotion by sodium barbital induces early development but does not increase the multiplicity of hereditary renal tumors in Eker rats. , 2000, Carcinogenesis.

[18]  H. Bartsch,et al.  Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. , 1999, International Journal of Cancer.

[19]  H. Bartsch,et al.  Sex‐ and strain‐specific expression of cytochrome P450s in Ochratoxin A‐induced genotoxicity and carcinogenicity in rats , 1998, Molecular carcinogenesis.

[20]  Stewart‐Tull Toxins , 1998 .

[21]  Edward R. Ashwood,et al.  Tietz Fundamentals of Clinical Chemistry , 1996 .

[22]  D. Hedley Chapter 16 DNA Analysis from Paraffin-Embedded Blocks , 1994 .

[23]  D. Hedley DNA analysis from paraffin-embedded blocks. , 1994, Methods in cell biology.

[24]  N. Konishi,et al.  Initiation by nickel acetate and promotion by sodium barbital of renal cortical epithelial tumors in male F344 rats. , 1990, Carcinogenesis.

[25]  G. Boorman Toxicology and carcinogenesis studies of ochratoxin a (CAS NO. 303-47-9) in F344/N rats (gavage studies) , 1989 .

[26]  M D Blaufox,et al.  Blood volume in the rat. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Makler Pt,et al.  Bone scintigraphy: differentiating benign cortical irregularity of the distal femur from malignancy. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  M. Roberfroid,et al.  Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis. , 1983, Carcinogenesis.

[29]  G. Williams,et al.  Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. , 1978, Journal of the National Cancer Institute.

[30]  H. Sugano,et al.  Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3'-methyl-4-(dimethylamino) azobenzene or diethylnitrosamine. , 1978, Gan.

[31]  F. M. Garner,et al.  Comparison of neoplasms in six sources of rats. , 1973, Journal of the National Cancer Institute.

[32]  W. Moloney,et al.  Spontaneous leukemia in Fischer rats. , 1970, Cancer research.